CytoSMART Technologies’ New Automated Live-Cell Imaging System Keeps Lab Teams Coordinated
The system is designed for users seeking to make side-by-side comparisons between cell cultures, run long-term experiments, and monitor cells while working remotely.
CytoSMART Technologies’ CytoSMART Multi Lux, a new automated live-cell imaging system, helps laboratory teams conduct long-term experiment runs and comparison studies and is useful for large teams.
The system is designed for users seeking to make side-by-side comparisons between cell cultures, run long-term experiments, and monitor cells from home while working remotely. The CytoSMART Multi Lux comes equipped with four sample stages for side-by-side comparison, label-free image analysis, and full remote access.
“An advanced live-cell imaging system consisting of four mini digital microscopes supported by automated image analysis software is especially useful for research groups that have been negatively impacted by COVID-19 restrictions and want to find new ways to continue their research,” said Joffry Maltha, CEO at CytoSMART Technologies, in a Sept. 10, 2020 company press release. “No matter how big your laboratory team is, this new Multi Lux technology lets scientists run up to four experiments simultaneously from inside the incubator at perfect culture conditions. Automated image analysis and immediate visualization of the results are accessible remotely via the CytoSMART Cloud. Besides, researchers who need to culture cells for weeks or even months, can also benefit from this long-term live-cell imaging solution without fear of needing to throw away cells because of failed experiments.”
The company launched the new product in September 2020.
Source: CytoSMART
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
